115265 ⎘
Glycosyltransferases (2.4); Hexosyltransferases (2.4.1) N-Acetyllactosaminide 3-alpha-galactosyltransferase (2.4.1.87), i.e. alpha-1,3-galactosyltransferase
CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION
#2CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION
#3TRANSGENIC CLONED PIG FOR XENOTRANSPLANTATION EXPRESSING HUMAN CD46 AND TBM GENES, IN WHICH PORCINE ENDOGENOUS RETROVIRUS ENVELOPE C IS NEGATIVE AND GGTA1, CMAH, iGb3s AND ß4GalNT2 GENES ARE KNOCKED OUT, AND METHOD FOR PREPARING SAME
#4DIAGNOSIS, PREVENTION AND TREATMENT OF DEMYELINATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM
#5CRISPR/Cas9 vector combination and application thereof in gene knockout
#6Therapeutic compositions and methods of use for treating cancer
#7Compositions and Methods for Increasing Immunogenicity of Glycoprotein Vaccines
#8Transgenic pig which simultaneously expresses HO-1 gene and TNFR1-Fc gene, and comprises knocked-out GGTA1 gene, and use thereof
#9THERAPEUTIC COMPOSITIONS AND METHODS OF USE FOR TREATING CANCER
#10Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#11Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity
#12Oncolytic heterologous recombinant newcastle disease virus, preparation method and application thereof
#13Multi-transgenic pigs for diabetes treatment
#14Fermentative production of oligosaccharides
#15CORRELATES OF EFFICACY RELATING TO TUMOR VACCINES
#16Multi-transgenic pigs for diabetes treatment
#17Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#18Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity
#19Selective antibody targeting of undifferentiated stem cells
#20Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region